Reducing barnyard emissions is one way to help reduce the harmful effects of tiny atmospheric air particles that can cause severe asthma in children, and lung cancer and heart attacks in some adults.
Data show significant asthma control and improved lung function with Symbicort.
The US Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair.
Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care.
Iloprost is an inhaled drug currently used to treat individuals with pulmonary arterial hypertension (raised blood pressure in the blood vessels in the lungs that leads to shortness of breath, dizziness and fainting). However, the results of a new study in mice indicate that iloprost might provide an effective therapeutic for the treatment of individuals with allergic asthma.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) received an educational grant from Genentech, Inc., and Novartis Pharmaceuticals Corporation to help patients better understand allergic asthma.
New research suggests that different treatments may be needed for chronic asthma, depending on whether it results from allergies or lung infections.
Health effects from childhood exposure to traffic pollution can last a lifetime in children. Living near a major highway or busy road in a city may halt lung development affecting lung function.
Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted. In fact, current recommendations in national and international asthma guidelines are based either on studies of single treatments compared to a placebo in children or on comparison studies in adults.
In a large, randomized, placebo-controlled study of 22,071 healthy male physicians, taking a low-dose of aspirin every other day lowered the risk of receiving an initial asthma diagnosis by 22 percent.